The 2026 Life Sciences EMEA Awards is now open for entries. We are looking forward to reviewing and celebrating the industry's most impressive achievements and landmarks from the past year.
With the submission deadline approaching, we sat down with our research team to provide top tips on how to make your firm stand out
The 2025 list of Rising Stars and Corporate Stars, produced by Managing IP’s accreditation title IP STARS, is now available
The location will be easily accessible for delegates visiting London for the INTA Annual Meeting
Sponsored
-
Sponsored by Adams & AdamsMohamed Jameel Hamid and Alicia van der Walt of Adams & Adams unpack the African Continental Free Trade Area agreement, explain its impact on intellectual property, and outline practical strategies for brand owners across Africa -
Sponsored by Adams & AdamsLauren Ross and Melissa Morris of Adams & Adams discuss the strategic opportunities and challenges in protecting non-traditional trademarks across the continent’s diverse legal and regulatory landscape
-
Sponsored by Spoor & FisherNew patent and utility model procedures and updated fees form part of a legislative update to the Bangui Agreement that became effective in the new year, explains Craig Kahn of Spoor & Fisher Jersey
Duarte Lima, MD of Spruson & Ferguson’s Asia practice, says practitioners must adapt to process changes within IP systems, as well as be mindful of the implications of tech on their practices
Qantm IP’s CEO and AI programme lead discuss the business’s investment and M&A plans, and reveal their tech ambitions
Tilleke & Gibbins topped the leaderboard with four awards across the region, while Anand & Anand and Kim & Chang emerged as outstanding domestic firms
Andrew Blattman, who helped IPH gain significant ground in Asia and Canada, will leave in the second half of 2026
Sponsored
-
Sponsored by HANOL ClassHankyul IP & LawPrecision medicine, also known as personalised medicine, is an emerging field in healthcare and seems to have a promising future as it accounts for 42% of new molecular entities which the Food and Drug Administration (FDA) approved in 2018. Since precision medicine aims to provide bespoke medical treatments based on individual patient's characteristics, it essentially incorporates diagnosis and treatment methods. Under Korean patent law and practice, treatment and diagnosis methods are not considered patent eligible subject matter. As such, it is necessary to circumvent restrictive eligibility requirements to obtain protection for precision medicines in Korea. In the past, although precision medicines can be pursued as a pharmaceutical/diagnostic composition claim, it was not easy to claim methodological aspects of precision medicines (e.g. dosage regimen) which were not considered as technical features constituting composition itself (Supreme Court decisions 2007Hu2926 and 2007Hu2933, rendered on May 28 2009).
-
Sponsored by HANOL ClassHankyul IP & LawIn Korea, patent term extension (PTE) of a maximum of five years may be granted once for a patent covering a drug or agrochemical that has to obtain marketing approval after patent registration. According to Article 95 of the Korean Patent Act, however, the scope of protection during the extended period is limited only to the working of the patented invention in relation to products whose marketing approval was the basis for PTE.
-
Sponsored by Remfry & SagarPankaj Soni of Remfry & Sagar analyses trends in AI, data concerns arising from AI, global subject matter eligibility standards for AI and whether AI can be classed as an inventor
Munich litigation boutique formed by former Taylor Wessing partners continues expansion as it seeks to cement its position in the UPC market
Our 2026 rankings for Western Europe, taken with historical data, reveal that some European IP markets hardly change – while others are more fluid
US corporates are using the UPC, but much of that work still flows to European boutiques. Last week’s merger, as well as others, could alter that dynamic
Our latest update also includes the latest case filing statistics, and an update on how a transatlantic merger could be a UPC opportunity for the US half of the partnership
Sponsored
-
Sponsored by MaiwaldKerstin Wolff of Maiwald explains how patents, plant variety rights, and new genomic techniques intersect in Europe, and what breeders and biotech innovators should consider when protecting plant intellectual property
-
Sponsored by Bugnion SpAFabio Angelini of Bugnion SpA examines whether the Kentucky ruling by the EUIPO Fourth Board of Appeal can be reconciled with the Iceland and Glashütte cases, and what it means for geographical trademarks
-
Sponsored by InspicosPeter Koefoed of Inspicos examines how the EPO Enlarged Board of Appeal referral G 1/26 could clarify the application of G 1/24 when assessing the allowability of amended patent claims under the EPC
A new foundation in Chile is giving women in the IP community the mentorship, and visibility they’ve long lacked
Firms are adapting litigation strategy as Brazil’s unique legal system and technical expertise have made preliminary injunctions a key tool in global patent disputes
Leaders at two Brazilian law firms outline strategies to adjust to trademark fee changes at Brazil's IP office while urging clients to apply before September 20
The LMG Life Sciences Awards announces the 2025 winners for the 13th annual awards!
Sponsored
-
Sponsored by Becerril, Coca & BecerrilStephania Cardiel of Becerril, Coca & Becerril examines how recent reforms signal a regional move towards faster, more internationally aligned innovation systems
-
Sponsored by Daniel LawRoberta Arantes of Daniel Law looks at how the Brazilian legal landscape has responded to shifts in the concept of branding and its related levels of protection
-
Sponsored by Daniel LawKene Gallois and Guilherme Coutinho of Daniel Law explain how the success of the plan will pave the way for Brazil to attract further investment and opportunities
The 2025 EMEA ceremony, held at the Royal Lancaster Hotel in London, also recognised in-house practitioners and rising stars
Ten firms have each received more than 11 nominations, while more than 20 in-house counsel are up for awards
We look ahead to next month’s EMEA Awards, discussing the recently published shortlists, our research methodology and what makes the Awards special
Managing IP will host a ceremony in London on April 10 to reveal the winners of the EMEA Awards 2025
Frederick Lee has rejoined Boies Schiller Flexner, bolstering the firm’s capabilities across AI, media, and entertainment
McGuireWoods’ focussed experimentation and disciplined execution of AI tools is sharpening its IP practice
As Marshall Gerstein celebrates its 70-year anniversary, Jeffrey Sharp, managing partner, reflects on lessons that shaped both his career and the firm’s success
Howard Hogan, IP partner at Gibson Dunn, says AI deepfakes are driving lawyers to rethink how IP protects creativity and innovation
Sponsored
-
Sponsored by Red PointsRed Points, in partnership with Managing IP hosted a webinar on April 7 at 9am PDT / 12pm EDT / 5pm BST to discuss best practices in uncovering and dismantling large-scale counterfeiters
-
Sponsored by OLIVARESMauricio Sámano of OLIVARES explores how the pandemic has changed IP processes for businesses in Mexico
-
Sponsored by OLIVARESSantiago Pedroza of OLIVARES looks at how the opposition procedure has undergone changes to protect right holders
